JPMorgan Chase & Co’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $596K | Sell |
|
|||||
|
2025
Q1 | $615K | Buy |
|
|||||
|
2024
Q4 | $942K | Sell |
|
|||||
|
2024
Q3 | $960K | Buy |
|
|||||
|
2024
Q2 | $710K | Sell |
|
|||||
|
2024
Q1 | $3.23M | Sell |
|
|||||
|
2023
Q4 | $12.6M | Sell |
|
|||||
|
2023
Q3 | $12.5M | Buy |
|
|||||
|
2023
Q2 | $17.7M | Buy |
|
|||||
|
2023
Q1 | $14M | Buy |
|
|||||
|
2022
Q4 | $6.68M | Buy |
|
|||||
|
2022
Q3 | $4.17M | Sell |
|
|||||
|
2022
Q2 | $3.44M | Sell |
|
|||||
|
2022
Q1 | $9.24M | Buy |
|
|||||
|
2021
Q4 | $5.47M | Buy |
|
|||||
|
2021
Q3 | $6.34M | Sell |
|
|||||
|
2021
Q2 | $10.5M | Sell |
|
|||||
|
2021
Q1 | $19.6M | Buy |
|
|||||
|
2020
Q4 | $5.81M | Buy |
|
|||||
|
2020
Q3 | $610K | Buy |
|
|||||
|
2020
Q2 | $169K | Sell |
|
|||||
|
2020
Q1 | $3.33M | Buy |
|
|||||
|
2019
Q4 | $1.55M | Sell |
|
|||||
|
2019
Q3 | $1.65M | Buy |
|
|||||
|
2019
Q2 | $1.88M | Sell |
|
|||||
|
2019
Q1 | $6.33M | Buy |
|
|||||
|
2018
Q4 | $2.02M | Buy |
|
|||||
|
2018
Q3 | $199K | Buy |
|
|||||
|
2018
Q2 | $88K | Sell |
|
|||||
|
2018
Q1 | $62K | Buy |
|
|||||
|
2017
Q4 | $59K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $122K | Sell |
|
|||||
|
2017
Q1 | $519K | Sell |
|
|||||
|
2016
Q4 | $500K | Buy |
|
|||||
|
2016
Q3 | $933K | Buy |
|
|||||
|
2016
Q2 | $386K | Buy |
|
|||||
|
2016
Q1 | $251K | Sell |
|
|||||
|
2015
Q4 | $535K | Buy |
|
|||||
|
2015
Q3 | $39K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $819K | Buy |
|
|||||
|
2014
Q4 | $310K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $84K | Sell |
|
|||||
|
2013
Q3 | $216K | Buy |
|
|||||
|
2013
Q2 | $28K | Buy |
|